Women's Health Events
From the FDA Office of Women's Health
FDA’s Office of Women’s Health (OWH) is pleased to present a series of educational webinars on a broad range of topics to promote, protect, and advance the health of women. These webinars target the needs of researchers, healthcare professionals, and students. Watch this space for new events in 2024!
Previous events
Hyperemesis Gravidarum: New Research and Insights
This webinar reviewed the latest research on maternal, fetal, and child adverse outcomes for the most severe form of nausea and vomiting caused by pregnancy, hyperemesis gravidarum. CME/CNE/CPE available.
Bringing Clinical Research to Patients
This webinar focused on decentralized clinical trials and other novel strategies currently available for bringing clinical research to patients. CME/CNE/CPE available.
Menopause: Potential Impact on Clinical Pharmacology
Speakers discussed the current understanding of the impact of menopause on the pharmacokinetics and pharmacodynamics, and exposure-response relationships of FDA-regulated drugs and biologics used by menopausal women for non-menopause-related indications.
PCOS Revisited: Diagnosis, Management, and Future Needs
This webinar reviewed the pathophysiology, diagnosis, comorbidities, and findings from recent research on Polycystic Ovary Syndrome.
More previous events
OWH offers recordings of previous events on a variety of women’s health topics, including CE for health professionals for some events.
OWH continuing education (CE)
OWH offers recordings of previous events for continuing education credit.